Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Apo-Lisdexamfetamine

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Capsule 60 mg DIN : 2546701
    • Capsule 10 mg DIN : 2546647
    • Capsule 20 mg DIN : 2546655
    • Capsule 30 mg DIN : 2546663
    • Capsule 40 mg DIN : 2546671
    • Capsule 50 mg DIN : 2546698

Pro-Lisdexamfetamine

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Pro-Doc Ltée (Pro Doc)
  • Strength and dosage form:
    • Capsule 60 mg DIN : 2547090
    • Capsule 10 mg DIN : 2547031
    • Capsule 20 mg DIN : 2547058
    • Capsule 30 mg DIN : 2547066
    • Capsule 40 mg DIN : 2547074
    • Capsule 50 mg DIN : 2547082

Lurasidone

Covered
  • Active ingredient(s):
  • Manufactured by:
    Sanis Health Inc. (Sanis)
  • Strength and dosage form:
    • Tablet 20 mg DIN : 2548585
    • Tablet 40 mg DIN : 2548593
    • Tablet 60 mg DIN : 2548607
    • Tablet 80 mg DIN : 2548615

NRA-Lurasidone

Covered
  • Active ingredient(s):
  • Manufactured by:
    Nora Pharma Inc. (Nora)
  • Strength and dosage form:
    • Tablet 20 mg DIN : 2522314
    • Tablet 40 mg DIN : 2522322
    • Tablet 60 mg DIN : 2522330
    • Tablet 80 mg DIN : 2522349

Fulphila

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Subcutaneous Injectable Solution syringe 10 mg/mL (0,6 mL) DIN : 2484153

Lapelga

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 10 mg/mL (0,6 mL) DIN : 2474565
    • Subcutaneous Injectable Solution (pen) 10 mg/mL (0,6 mL) DIN : 2529343

Nyvepria

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Subcutaneous Injectable Solution syringe 10 mg/mL (0,6 mL) DIN : 2506238

Ziextenzo

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    Subcutaneous Injectable Solution syringe 10 mg/mL (0,6 mL) DIN : 2497395

Orgovyx

Covered
  • Active ingredient(s):
  • Manufactured by:
    Sumitomo Pharma (Sumitomo)
  • Strength and dosage form:
    Tablet 120 mg DIN : 2542137

M-Rivaroxaban

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    • Tablet 10 mg DIN : 2551616
    • Tablet 15 mg DIN : 2551624
    • Tablet 20 mg DIN : 2551632
    • Tablet 2.5 mg DIN : 2551608

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.